The bioavailability and urinary excretion of three dietary flavonoids, quercetin, hesperetin and naringenin, were investigated. Ten healthy men were asked to consume a 'juice mix' containing equal amounts of the three flavonoids, and their urine and plasma samples were collected. The resulting mean plasma area under the curve (AUC) 0À48h and C max values for quercetin and hesperetin were similar, whereas the AUC 0À48h of naringenin and, thus, the relative bioavailability were higher after consumption of the same dose. The study consolidates a significantly lower urinary excretion of quercetin (1.5 ± 1%) compared with hesperetin (14.2±9.1%) and naringenin (22.6±11.5%) and shows that this is not due to a lower bioavailability of quercetin, but rather reflects different clearance mechanisms. ( To compare the impact of dietary important flavonoids, it is necessary to study them in the same food matrix and at similar realistic doses. The present study investigates the bioavailability and urinary excretion of the flavonoids, quercetin, hesperetin and naringenin, in a 48-h intervention study with a single dose (6.3 ml/kg b.w.) of 'juice mix' containing the three flavonoids.
To compare the impact of dietary important flavonoids, it is necessary to study them in the same food matrix and at similar realistic doses. The present study investigates the bioavailability and urinary excretion of the flavonoids, quercetin, hesperetin and naringenin, in a 48-h intervention study with a single dose (6.3 ml/kg b.w.) of 'juice mix' containing the three flavonoids.
Complete urine and plasma samples were obtained from 10 healthy men, aged 21-28 years. The study was approved by the ethics committee of Copenhagen and Frederiksberg municipality (J.No.(KF)01-161/01). The 'juice mix' was provided to fasting individuals in the morning, along with a standardized flavonoid-free diet (0-24 h), after which the individuals maintained a flavonoid-free diet (24-48 h). Blood and urine samples were collected as described previously (Nielsen et al., 2006) . Flavonoid aglycones were quantified in the 'juice mix' (30 mg/l quercetin, 28 mg/l naringenin and 32 mg/l hesperetin) and flavonoid glycosides in the 'juice mix' were identified according to Breinholt et al. (2003) .
Flavonoids in plasma were completely hydrolysed as described in Nielsen et al. (2006) . Plasma samples were added 25 ml aqueous ascorbic acid (20 mg/ml) and 0.5% formic acid to pH ¼ 4 and applied to Evolute ABN columns (25 mg, Mikrolab, Aarhus, Denmark). The eluted flavonoid aglycones were evaporated to dryness and re-dissolved in 200 ml 0.5% formic acid and 10% methanol, and 250 ng 13 C-daidzein was added as external standard.
Determination of flavonoids in urine is essentially described elsewhere (Nielsen et al., 2006) , except for the inclusion of solid-phase extraction (Isolute SPE 100, Mikrolab) before injection into the liquid chromatographymass spectrometry system. Statistical analyses were performed using Wilcoxon matched pair tests (SPSS version 14.0). The relative bioavailability, area under the curve (AUC) 0À48h , was calculated using the linear trapezoidal rule.
Results and discussion
This study demonstrates that when individuals consume equal amounts of quercetin and hesperetin, the AUC 0À48h , and thus the bioavailabilities of these flavonoids, is similar. However, the AUC 048h of naringenin was significantly higher than that for quercetin and hesperetin (Figure 1 ). In addition, plasma C max levels achieved for quercetin and hesperetin were comparable, whereas the level achieved for naringenin was significantly higher (Table 1 ). In the study design we assumed that the low and natural amounts of flavonoids in the 'juice mix' excluded any interference with respect to pharmacokinetics of the flavonoids investigated. Previous studies dealing with flavanone and flavonol bioavailability report AUC values in the same range (Hollman et al., 1997; Erlund et al., 2001; Manach et al., 2003 Manach et al., , 2005 as observed in the current study. However, the lack of blood sampling between 8-24 h in the present study may have caused an overestimation of the AUCs, especially for the flavanones.
In the present study, we observed a 9-15-fold higher urinary excretion of naringenin and hesperetin compared with quercetin (Table 1) , consolidating the apparent paradox that absorption and bioavailability of the three flavonoids seem quite similar, but that urinary excretion is highly different. The low urinary recovery (1.5%) of the ingested quercetin leaves a large amount of the ingested dose unaccounted for compared with hesperetin and naringenin. The most likely fate of the absorbed quercetin is excretion via bile (Matsukawa et al., 2009) and further degradation to low-molecular-weight phenolic acids that were not analysed in the current and most previous flavonol bioavailability studies (Mullen et al., 2006 (Mullen et al., , 2008 . Only small amounts of the 3 0 -methylated form of quercetin, isorhamnetin, were present in the 'juice mix' (1.8 mg/500 ml 'juice mix'), and of this only 4.1 ± 3.3% of isorhamnetin was excreted in urine after 48 h, excluding extensive methylation of quercetin. Only trace amounts of tamarexetin (4 0 -OMe-quercetin) were found in juice, plasma and urine.
Hydrolysis of the flavonoid glycoside moiety is a necessary step for absorption of flavonoids from the gut. In the present study, apple juice was the source of quercetin and qualitative liquid chromatography-mass spectrometry investigation of the 'juice mix' showed that approximately 60% of the quercetin was present as monoglycosides, 25% as aglycone and less than 15% as rutinosides. It has been shown that only quercetin-3-glucoside and quercetin-4 0 -glucoside are absorbed in substantial quantities, whereas only small quantities of quercetin-3-galactoside, quercetin-3-rhamnoside and quercetin-3-arabinoside are absorbed in the small intestine, but are hydrolysed and absorbed in the distal part of the colon together with diglycosides such as naringin and hesperidin (Arts et al., 2004) . More than 99% of the hesperetin and naringenin in the 'juice mix' were diglycosides, presumably naringin and hesperidin. The nature of the glycoside moieties bound to the three flavonoids was, thus, mainly in a form that favours absorption from the colon. The similar T max values for quercetin, hesperetin and naringenin in the current study support this assumption. T max for quercetin in the literature is between 1-9 h, depending on sugar moiety composition (Manach et al., 2005) , and the intermediate T max (3.6 ± 1.6 h) in the present study correlates with the mixed content of quercetin glycosides. The average T max in the literature for naringenin is between 2.0-4.6 h (Manach et al., 2003) and that for hesperetin between 5.4-5.8 h (Manach et al., 2003) , and are thus also in the same range as observed here.
In conclusion, the current study confirms a lower urinary excretion of quercetin compared with naringenin and hesperetin. The study furthermore shows that the significantly lower urinary excretion of quercetin is not due to a low bioavailability of quercetin, but rather reflects the different clearance mechanisms of this flavonoid.
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